Table of Contents Table of Contents
Previous Page  21 / 266 Next Page
Information
Show Menu
Previous Page 21 / 266 Next Page
Page Background

XV

Andrew M. Fuchs

, University of Wisconsin, Madison

1168-Pos, B145

NASCENT PROTEINS INTERACT WITH KEY REGIONS OF THE OUTER

SURFACE OF THE RIBOSOME.

Leland B. Gee

, University of California, Davis

1592-Pos, B569

A GATED SUBSTRATE CHANNEL REVEALED IN NITROGENASE THROUGH

A COMBINED IR AND MOLECULAR DYNAMICS STUDY.

Bence Hegyi

, University of California, Davis

1347-Pos, B324

CAMKII INHIBITOR KN-93 DIRECTLY BLOCKS IKR IN CARDIAC

MYOCYTES.

Stephania Irwin

, University of Alberta

1143-Pos, B120

INFLUENCE OF FAMILIAL PARKINSON’S DISEASE MUTATIONS ON

MITOCHONDRIAL LOCALIZATION AND SECONDARY STRUCTURE OF

PINK1.

Pei-I Ku

, University of Utah

1072-Pos, B49

REGULATION OF ALIX DURING EXOCYTIC VESICLE RELEASE AND

ASSEMBLY OF ESCRT PROTEINS ON THE PLASMA MEMBRANE.

Jayson V. Lingan

, University of Rochester Medical Center

1518-Pos, B495

PERMEABILITY TRANSITION PORE CLOSURE INCREASES

MITOCHONDRIAL MATURATION AND MYOCYTE DIFFERENTIATION IN

THE NEONATAL HEART.

William Marsiglia

, New York University

1097-Pos, B74

NMR EXPERIMENTS ON WILD-TYPE AND MUTANT FIBROBLAST

GROWTH FACTOR RECEPTOR KINASES REVEAL CONFORMATIONAL

DYNAMICS ASSOCIATED WITH ENZYME ACTIVATION.

Favinn A. Maynard

, University of Colorado, Denver

1258-Pos, B235

MECHANISM OF STRONG MEMBRANE BINDING BY SYNAPTOTAGMIN

7 C2A DOMAIN: INSIGHT FROM MUTATION AND LIPID COMPOSITION

DEPENDENCE.

Joshua Mayourian

,

Icahn School of Medicine at Mount Sinai

1340-Pos, B317

MODELING ELECTROPHYSIOLOGICAL INTERACTIONS BETWEEN

MESENCHYMAL STEM CELLS AND CARDIOMYOCYTES FOR IMPROVED

CELL DELIVERY CARDIOTHERAPEUTICS.

Keith J. Mickolajczyk

, Pennsylvania State University

961-Plat

KINETICS OF NUCLEOTIDE-DEPENDENT STRUCTURAL TRANSITIONS IN

THE KINESIN-1 HYDROLYSIS CYCLE.

Rami Musharrafieh

, University of Arizona

1279-Pos, B256

COMPUTATIONAL AND EXPERIMENTAL STUDIES OF LIPID-PROTEIN

INTERACTIONS IN BIOMEMRANE FUNCTION.

Premila Samuel

, Rice University

1043-Pos, B20

AN IN VITRO INVESTIGATION OF GLOBIN FOLDING AND EXPRESSION.

Caitlin E. Scott

, University of Kentucky

1039-Pos, B16

MOLECULAR DYNAMICS STUDY OF DIVALENT ION COORDINATION IN

EF HAND PROTEINS.

M. de la Encarnacion Solesio Torregrosa

, New York University College

of Dentistry

1524-Pos, B501

CONTRIBUTION OF INORGANIC POLYPHOSPHATE TOWARDS

REGULATION OF MITOCHONDRIAL FREE CALCIUM.

Cholpon Tilegenova

, Texas Tech University Health Sciences Center

1370-Pos, B347

ELUCIDATION OF MOLECULAR MECHANISM UNDERLYING KCSA’S

HYSTERETIC GATING BEHAVIOR.

Yan Yan

, Emory University

1173-Pos, B150

HU PROTEIN AND DNA SUPERCOILING DRAMATICALLY ENHANCE LAC-

REPRESSOR-MEDIATED DNA LOOPING.

Fabio C. Zegarra

, University of Houston

1051-Pos, B28

THE COMBINED EFFECT OF MACROMOLECULAR CROWDING AND

CHEMICAL INTERFERENCE ON THE DYNAMICS OF APOAZURIN FOLDING.

Qiangjun Zhou

, Stanford University

1561-Pos, B538

MOLECULAR MECHANISM OF THE SYNAPTOTAGMIN-SNARE

COMPLEX THAT IS ESSENTIAL FOR SYNCHRONOUS SYNAPTIC

NEUROTRANSMITTER RELEASE.

Tuesday

Sinan Can

, University of California, Berkeley

2259-Pos, B403

KINESIN’S FRONT HEAD IS GATED BY THE BACKWARD ORIENTATION OF

ITS NECK LINKER.

Irem Celen

, University of Delaware

1727-Plat

MULTI-SCALE SPATIO-TEMPORAL DYNAMICS OF HISTONE

MODIFICATIONS.

Robert E. del Carlo

, University of Nevada School of Medicine

2161-Pos, B305

POINT-MUTATIONS IN SKELETAL MUSCLE VOLTAGE-GATED SODIUM

CHANNELS CONFER RESISTANCE TO TETRODOTOXIN: BUT AT A COST?

Jeevan B. Gc

, Florida International University

1862-Pos, B6

INTERDOMAIN INTERACTIONS AND THE MECHANISM OF STRUCTURAL

TRANSFORMATION IN RFAH.

Nnanya U. Kalu

, The Catholic University of America

2094-Pos, B238

DOES LIPID COMPOSITION REGULATE ANTHRAX TOXIN UPTAKE?

Minmin Luo

,

Louisiana State University School of Medicine and Health

Sciences Center

2266-Pos, B410

TRAPPING THE TRANSITION STATE OF KINESIN-5 PRODUCES A

DIFFERENT MULTIMOTOR FORCE OUTCOME THAN INHIBITING

PRODUCT RELEASE.